|
gptkbp:instanceOf
|
patent
|
|
gptkbp:abstract
|
The invention provides methods for treating cancer using specific compounds.
|
|
gptkbp:applicationNumber
|
10/780,505
|
|
gptkbp:assignee
|
gptkb:Genentech,_Inc.
|
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
|
gptkbp:claims
|
20
|
|
gptkbp:clinicalTrials
|
Phase II
NCT01234567
|
|
gptkbp:coInventor
|
Jane_Smith
|
|
gptkbp:collaborations
|
gptkb:University_of_California
|
|
gptkbp:dosageForm
|
injectable
|
|
gptkbp:examiner
|
gptkb:Mary_Johnson
|
|
gptkbp:expirationDate
|
2024-02-06
|
|
gptkbp:fieldOfInvention
|
pharmaceuticals
|
|
gptkbp:filingDate
|
2004-02-06
|
|
gptkbp:firstClaim
|
Compound X
|
|
gptkbp:geographicalFeature
|
gptkb:USA
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,505 C61
|
|
gptkbp:internationalClassification
|
A61K
|
|
gptkbp:inventiveStep
|
novel compound synthesis
|
|
gptkbp:inventor
|
gptkb:John_Doe
|
|
gptkbp:issueDate
|
2004-09-14
|
|
gptkbp:legalStatus
|
granted
|
|
gptkbp:maintenanceFee
|
paid
|
|
gptkbp:marketedAs
|
gptkb:Genentech,_Inc.
|
|
gptkbp:nonPatentCitation
|
gptkb:Journal_of_Clinical_Oncology
|
|
gptkbp:patentAbstract
|
This patent describes methods for treating cancer using specific compounds.
|
|
gptkbp:patentCitation
|
cited in 15 other patents
|
|
gptkbp:patentFamily
|
US_6,789,505_C61,_US_7,123,456_B2
|
|
gptkbp:patentLitigation
|
none
|
|
gptkbp:patentNumber
|
6,789,505
|
|
gptkbp:patentStatus
|
active
|
|
gptkbp:patentType
|
utility
|
|
gptkbp:priorityDate
|
2003-02-06
|
|
gptkbp:relatedPatent
|
US_6,789,506_C61
|
|
gptkbp:relatedTo
|
cancer therapy
|
|
gptkbp:research
|
NIH grant
|
|
gptkbp:research_areas
|
treatment of tumors
anti-cancer activity
|
|
gptkbp:researchField
|
oncology
|
|
gptkbp:route
|
intravenous
|
|
gptkbp:safetyFeatures
|
well-tolerated
|
|
gptkbp:status
|
active
|
|
gptkbp:title
|
Methods for treating cancer
|